三個皮匠報告
政策庫
new
付費
搜索

SMILE研究結果：ACR20和無進展患者百分比（FAS)-行業數據

SMILE研究結果：ACR20和無進展患者百分比（FAS)
SMILE研究結果：ACR20和無進展患者百分比（FAS)
SMILE 研究結果表明艾拉莫德單藥長期療效優于甲氨蝶呤。甲氨蝶呤是臨床一線治療RA 的錨定藥物。根據 2021 年歐洲風濕病學大會（EULAR）公布的一項隨機、雙盲、平行對照、多中心 SMILE 研究結果，在治療 52 周時，艾拉莫德單藥和艾拉莫德聯合甲氨蝶呤的 ACR20（美國風濕病學會 20%改善標準）應答率分別為 77.44%(230/297，P=0.0019)和 77.05%(235/305，P=0.0028)，均顯著優于甲氨蝶呤單藥治療的 65.87%(193/293)。且在安全性方面，三組無明顯差異。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?9KB 圖片尺寸：1830*789
同報告圖片
 / 69
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第1頁
fCBBQ1IyMCB8IOaXoOi/m+WxleaCo+iAheeZvuWIhuavlCB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CgoK6LWE5paZ5p2l5rqQ77yaRXVsYXIgMjAyMQ==
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第2頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第3頁
fOW5tOS7vXznvLrooYDmgKfohJHljZLkuK0o5LiH5Lq6KXzlh7rooYDmgKfohJHljZLkuK0o5LiH5Lq6KXwKfC18LXwtfAp8MjAwNXwwfDB8CnwyMDA2fDB8MHwKfDIwMDd8MHwwfAp8MjAwOHwwfDB8CnwyMDA5fDB8MHwKfDIwMTB8MHwwfAp8MjAxMXwwfDB8CnwyMDEyfDB8MHwKfDIwMTN8MHwwfAp8MjAxNHwwfDB8CnwyMDE1fDB8MHwKfDIwMTZ8MHwwfAp8MjAxN3wwfDB8CnwyMDE4fDB8MHwKfDIwMTl8MHwwfAoK6LWE5paZ5p2l5rqQ77ya44CK5Lit5Zu95Y2r55Sf57uf6K6h5bm06Ym044CLKOWbveWutuWNq+WBpeWnlO+8jOi9rOW8leiHquWFrOWPuOaKlei1hOiAhea8lA==
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第4頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第5頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第6頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第7頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第8頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第9頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第10頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第11頁
fCDml7bpl7QgICAgICAgfCDllJHlkKHlnaYgfCDkvZDljLnlhYvpmoYgfCDoib7lj7jllJHku5EgfCDlj7PkvZDljLnlhYvpmoYgfCDmiY7mnaXmma7pmoYgfCDoi6/lt7Tmr5TlpqUgfCDlhbbku5YgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLXwKfCAyMDIwUTMgICAgIHwgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgfCAgICAgICAgIHwgICAgICB8CnwgMjAyMFE0ICAgICB8ICAgICAgICB8ICAgICAgICAgIHwgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICB8ICAgICAgfAp8IDIwMjFRMSAgICAgfCAgICAgICAgfCAgICAgICAgICB8ICAgICAgICAgfCAgICAgICAgICAgIHwgICAgICAgICB8ICAgICAgICAgfCAgICAgIHwKfCAyMDIxUTIgICAgIHwgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgfCAgICAgICAgIHwgICAgICB8CnwgMjAyMVEzICAgICB8ICAgICAgICB8ICAgICAgICAgIHwgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICB8ICAgICAgfAp8IDIwMjFRNCAgICAgfCAgICAgICAgfCAgICAgICAgICB8ICAgICAgICAgfCAgICAgICAgICAgIHwgICAgICAgICB8ICAgICAgICAgfCAgICAgIHwKfCAyMDIyUTEgICAgIHwgICAgICAgIHwgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgfCAgICAgICAgIHwgICAgICB8CnwgMjAyMlEyICAgICB8ICAgICAgICB8ICAgICAgICAgIHwgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgIHwgICAgICAgICB8ICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaUERC5pWw5o2u5bqT77yM5Lit5L+h6K+B5Yi456CU56m26YOo
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第12頁
fCDllJHlkKHlnaYgfCDkvZDljLnlhYvpmoYgfCDoib7lj7jllJHku5EgfCDlj7PkvZDljLnlhYvpmoYgfCDmiY7mnaXmma7pmoYgfCDojLblt7Tmr5TlpqUgfCDlhbbku5YgIHwKfC0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS18CnwgNDAuMzQlIHwgMjMuODklIHwgMjEuNjYlIHwgMTAuMjIlIHwgMy4wMCUgfCAwLjUyJSB8IDAuMzclIHwKCui1hOaWmeadpea6kDogUERCIOaVsOaNruW6k++8jOS4reS/oeivgeWIuOeglOeptumDqA==
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第13頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第14頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第15頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第16頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第17頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第18頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第19頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第20頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第21頁
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOaBtuaAp+iDuOiFlOenr+a2sueYpOenjeexuyB8IOeZvuWIhuavlCB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tfAp8IOiCuueZjCAgICAgICAgICAgICAgICAgIHwgNDAlICAgIHwKfCDkubPohbrnmYwgICAgICAgICAgICAgICAgfCAyMCUgICAgfAp8IOaBtuaAp+a3i+W3tOeYpCAgICAgICAgICAgIHwgMjAlICAgIHwKfCDlhbbku5YgICAgICAgICAgICAgICAgICB8IDIwJSAgICB8CgrotYTmlpnmnaXmupDvvJrjgIrph43nu4TkurrooYDnrqHlhoXnmq7mipHliLbntKDmsrvnlpfmgbbmgKfmtYbohpzohZTnp6/mtrLkuLTluorlupTnlKjkuJPjgIs=
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第22頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第23頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第24頁
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yM5Lul5Y+K6LWE5paZ5p2l5rqQ77yaCgp8IOayu+eWl+aWueazlSAgIHwgbVRUUOe7k+aenO+8iOWkqe+8iSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwKfCDmganluqYgICAgICAgfCA2OSAgICAgICAgICAgICB8Cnwg6aG66ZOCICAgICAgIHwgNDUgICAgICAgICAgICAgfAp8IOaBqeW6pivpobrpk4IgIHwgNjkgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya44CK6YeN57uE5Lq66KGA566h5YaF55qu5oqR5Yi257Sg5rK755aX5oG25oCn5rWG6Iac6IWU56ev5ray5Li05bqK5bqU55So5LiT
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第25頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第26頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第27頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第28頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第29頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第30頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第31頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第32頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第33頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第34頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第35頁
fCBBQ1IyMCB8IOaXoOi/m+WxleaCo+iAheeZvuWIhuavlCB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CnwgICAgICAgIHwgICAgICAgICAgICAgICAgICB8CgoK6LWE5paZ5p2l5rqQ77yaRXVsYXIgMjAyMQ==
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第36頁
fCBBQ1IyMCB8IEFDUjUwIHwgQUNSNzAgfAp8LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18CnwgMTLlkag6IDYwIHwgMTLlkag6IDMwIHwgMTLlkag6IDEwIHwKfCAyNOWRqDogNzAgfCAyNOWRqDogNDUgfCAyNOWRqDogMjUgfAoK6LWE5paZ5p2l5rqQOiDjgIpFZmZlY3RpdmVuZXNzIGFuZCBzYWZldHkgb2YgaWd1cmF0aW1vZCB0cmVhdG1lbnQgaW4=
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第37頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第38頁
fCBTaW1jZXJlIFBoYXJtYWNldXRpY2FsIEhvbGRpbmcgTGltaXRlZCB8IOmbheaZr+eOr+eQg+aciemZkOWFrOWPuCB8IOS9s+WOn+aKlei1hOaciemZkOWFrOWPuCB8IFNpbWNlcmUgSW52ZXN0bWVudHMgR3JvdXAgTGltaXRlZCB8IOWFtuS7liAgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgNDUuMTklIHwgMjIuOTMlIHwgNC41NyUgfCA0LjM2JSB8IDIyLjk1JSB8
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第39頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第40頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第41頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第42頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第43頁
fCDml6XmnJ8gfCBQYXhsb3ZpZCB8IE1vbG51cGlyYXZpciB8CnwtLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCAyMDIxUTQgfCAwLjc2IHwgOS41MiB8CnwgMjAyMlExIHwgMTQuNyB8IDMyLjUgfAp8IDIwMjJRMiB8IDgxLjE1IHwgMTIgfAp8IDIwMjJRMyB8IDc1LjE0IHwgNC4zNiB8CgrotYTmlpnmnaXmupDvvJrovonnkZ7jgIHpu5jlhYvlhazlj7jlhazlkYrvvIzkuK3kv6Hor4HliLjnoJTnqbbpg6g=
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第44頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第45頁
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM5Lul5LiL5piv5YWs5Y+45q+b5Yip546H5rC05bmz55qE6KGo5qC877yaCgp8IOW5tOS7vSAgIHwg5q+b5Yip546H5rC05bmzIHwKfC0tLS0tLS0tfC0tLS0tLS0tLS0tLXwKfCAyMDE3ICAgfCA4NC4wMCUgICAgIHwKfCAyMDE4ICAgfCA4Mi41MCUgICAgIHwKfCAyMDE5ICAgfCA4MS4wMCUgICAgIHwKfCAyMDIwICAgfCA3OS4wMCUgICAgIHwKfCAyMDIxICAgfCA3OC4wMCUgICAgIHwKfCAyMDIySDEgfCA3OS4wMCUgICAgIHwKCui1hOaWmeadpea6kO+8mldpbmTvvIzkuK3kv6Hor4HliLjnoJTnqbbpg6g=
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第46頁
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM55Sf5oiQ55qE6KGo5qC85aaC5LiL77yaCgp8IOW5tOS7vSAgfCDlh4DliKnnjofmsLTlubMgfAp8LS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgMjAxNyAgfCAxMC4wMCUgICAgIHwKfCAyMDE4ICB8IDE1LjAwJSAgICAgfAp8IDIwMTkgIHwgMjAuMDAlICAgICB8CnwgMjAyMCAgfCAxNS4wMCUgICAgIHwKfCAyMDIxICB8IDMwLjAwJSAgICAgfAp8IDIwMjJIMXwgNS4wMCUgICAgICB8CgrotYTmlpnmnaXmupDvvJpXaW5k77yM5Lit5L+h6K+B5Yi456CU56m26YOo
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第47頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第48頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第49頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第50頁
fCDlubTku70gfCDnoZXlo6vkurrmlbAgfCDljZrlo6vkurrmlbAgfCDmgLvkurrmlbAgfAp8LS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLXwKfCAyMDE35bm0IHwgMjkgfCA5NSB8IDIyMCB8CnwgMjAyMeW5tCB8IDExOCB8IDQ3NSB8IDk1MCsgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45oqV6LWE6ICF5ryU56S65p2Q5paZ77yM5Lit5L+h6K+B5Yi456CU56m26YOo
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第51頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第52頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第53頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第54頁
5aW955qE77yM5Lul5LiL5piv5LuO5Zu+54mH5Lit5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOS4tOW6iuaMh+WNl+WIhuexuyB8IOWFiOW/heaWsCB8IOaBqeW/heaZriB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCDkvZznlKjmnLrliLYgICAgIHwg5oqX54KO5ZKM6Ieq55Sx5Z+65riF6Zmk5Y+M6YeN5py65Yi277yM6Zi75pat5Y2S5Lit5ZCO56We57uP5YWD5o2f5Lyk77yI5Y2S5Lit5Y+N5bqU5LiL5ri477yJIHwg6ZmN5L2O6IOe5YaF6ZKZ56a75a2Q5rWT5bqm44CB5oqR5Yi26LC35rCo6YW46YeK5pS+44CB5riF6Zmk5rCn6Ieq55Sx5Z+6562J77yM5pS55ZaE6ISR57y66KGA5Yy655qE5b6u5b6q546v5ZKM6KGA5rWB6YeP77yI5Y2S5Lit5YmN77yJIHwKfCDliYLlnosgICAgICAgICB8IOazqOWwhOWJgiB8IOazqOWwhOWJgiB8Cnwg6IiM5LiL54mH77yI5bCa5pyq5LiK5biC77yJIHwg6L2v6IO25ZuKIHwKfCDopobnm5bljLvpmaLmlbDph48gfCAzMDAwLTQwMDDlrrYgfCA3MDAwLTgwMDDlrrYgfAp8IDIwMjHlubTplIDllK7pop0gfCDnuqYxNeS6v+WFgyB8IOe6pjY25Lq/5YWDIHwKfCAyMDIy5bm06aKE6K6h6ZSA5ZSu6aKdIHwg57qmMjLkur/lhYMgfCDnuqY3MOS6v+WFgyB8Cnwg5LiT5Yip5pyf6ZmQICAgICB8IOWkhOS6juWVhuS4muWMluaXqeacn++8jOS4k+WIqeacn+mZkOi+g+mVv++8iOWmguS4jeeUs+ivt+W7tumVv++8jOacgOaXqTIwMjnlubTov4fmnJ/vvIkgfCDms6jlsITliYLkuJPliKkyMDIy5bm05bey6L+H5pyfIHwKfCDova/og7blm4rliYLkuJPliKkyMDIz5bm06L+H5pyfIHwgIHwKfCDms6jlsITliYLljZXku7cgICB8IDQ4LjjlhYMvNW1MIHwgMTM55YWDLzEwMG1MIHwKfCDms6jlsITliYLnlKjms5XnlKjph48gfCAxNOaXpe+8jOavj+aXpTLmrKHvvIzmr4/mrKExNW1MIHwgMTTml6XvvIzmr4/ml6Uy5qyh77yM5q+P5qyhMTAwbUwgfAp8IOazqOWwhOWJguayu+eWl+i0ueeUqCB8IDQwOTnlhYMv55aX56iLIHwgMzg5MuWFgy/nlpfnqIsgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45a6Y572R77yM55+z6I2v6ZuG5Zui5a6Y572R77yM44CK5Lit5Zu95oCl5oCn57y66KGA5oCn6ISR5Y2S5Lit6K+K5rK75oyH5Y2XMjAxOOOAi++8jOWFiOW/heaWsOiNr+WTgeivtOaYjuS5pu+8jOaBqeW/heaZruiNr+WTgeivtOaYjuS5puOAgg==
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第55頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第56頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第57頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第58頁
5aW955qE77yM5Lul5LiL5piv5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM5bm25Zyo6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ77yaCgp8IOeUqOiNryAgICAgICAgIHwg5puy5ouJ6KW/5YipK+aIiOaymeWmpeePoOWNleaKlyB8IOaIiOaymeWmpeePoOWNleaKlyB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IOaVsOaNruadpea6kCAgICAgfCDml6nmnJ9JSeacn+S4tOW6iiAgICAgICAgIHwgQVNDRU5U5Li05bqKSUlJ5pyf56CU56m2IHwKCui1hOaWmeadpea6kO+8muaXqeacn0lJ5pyf5Li05bqK5ZKMQVNDRU5U5Li05bqKSUlJ5pyf56CU56m244CC
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第59頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第60頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第61頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第62頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第63頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第64頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第65頁
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第66頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第67頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第68頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第69頁
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
SMILE研究結果：ACR20和無進展患者百分比（FAS)_第70頁
所屬報告： 先聲藥業-港股投資價值分析報告：革故鼎新轉型迭代正當時的制藥龍頭-230114（65頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站